Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
58.22
-0.03 (-0.05%)
Nov 5, 2025, 4:00 PM EST - Market closed
Utah Medical Products Revenue
Utah Medical Products had revenue of $9.81M in the quarter ending September 30, 2025, a decrease of -1.93%. This brings the company's revenue in the last twelve months to $38.63M, down -12.35% year-over-year. In the year 2024, Utah Medical Products had annual revenue of $40.90M, down -18.56%.
Revenue (ttm)
$38.63M
Revenue Growth
-12.35%
P/S Ratio
4.94
Revenue / Employee
$231,335
Employees
167
Market Cap
186.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.90M | -9.32M | -18.56% |
| Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
| Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
| Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
| Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
UTMD News
- 1 day ago - Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend - Accesswire
- 13 days ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025 - Accesswire
- 3 months ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 3 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025 - Accesswire
- 4 months ago - Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest - Seeking Alpha
- 6 months ago - Stock Picks From Seeking Alpha's April 2025 New Analysts - Seeking Alpha
- 6 months ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025 - Accesswire
- 7 months ago - Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open - Seeking Alpha